Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-24-264726
Filing Date
2024-11-25
Accepted
2024-11-25 07:50:26
Documents
4
Period of Report
2024-11-25

Document Format Files

Seq Description Document Type Size
1 6-K d890871d6k.htm 6-K 12021
2 EX-99.1 d890871dex991.htm EX-99.1 245818
3 EX-99.2 d890871dex992.htm EX-99.2 93321
4 EX-99.3 d890871dex993.htm EX-99.3 94216
  Complete submission text file 0001193125-24-264726.txt   446480
Mailing Address 3 LOCHSIDE WAY EDINBURGH X0 EH12 9DT
Business Address 3 LOCHSIDE WAY EDINBURGH X0 EH12 9DT 44-0-131-357-1111
NuCana plc (Filer) CIK: 0001709626 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38215 | Film No.: 241491978
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)